The feasibility of HIV vaccine efficacy trials among Russian injection drug users

Vaccine

Volumn 25, Issue 41, 2007, Pages 7014-7016

  Beyrer, Chris ^a   Baral, Stefan ^a   Shaboltas, Alla ^b   Dukhovlinova, Elena ^b   Masharsky, Alexey ^b   Verevochkin, Sergey ^b   Latkin, Carl ^a   Heimer, Robert ^c   Hoffman, Irving ^d   Kozlov, Andrei ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Biomedical Center   (Russian Federation)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

HIV; Injection drug use; Molecular epidemiology; St. Petersburg; Vaccines

Indexed keywords

ANTIRETROVIRUS AGENT; BUPRENORPHINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; METHADONE; NALTREXONE;

ARTICLE; CLINICAL TRIAL; DETOXIFICATION; DRUG DEPENDENCE; DRUG EFFICACY; EPIDEMIC; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; GENETIC VARIABILITY; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INTRAVENOUS DRUG ADMINISTRATION; METHADONE TREATMENT; MOLECULAR EPIDEMIOLOGY; PREVALENCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; VIRUS STRAIN; VIRUS TRANSMISSION;

AIDS VACCINES; HIV; HIV INFECTIONS; HUMANS; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34648831918     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.028     Document Type: Article

References (19)

1. Aceijas C., Stimson G.V., Hickman M., Rhodes T., and United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18 17 (2004) 2295-2303
2. Field M.G. HIV and AIDS in the Former Soviet Bloc. N Engl J Med 351 2 (2004) 117-120
3. Dehne K.L., Khodakevich L., Hamers F.F., and Schwartlander B. The HIV/AIDS epidemic in eastern Europe: recent patterns and trends and their implications for policy-making. AIDS 13 7 (May 7, 1999) 741-749
4. Rhodes T., Platt L., Maximova S., Koshkina E., Latishevskaya N., Hickman M., et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 101 2 (2006) 252-266
5. McMichael A.J. HIV vaccines. Annu Rev Immunol 24 (2006) 227-255
6. Kozlov A.P., Shaboltas A.V., Toussova O.V., Verevochkin S.V., Masse B.R., Perdue T., et al. HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS 20 6 (2006) 901-906
7. Shaboltas A.V., Toussova O.V., Hoffman I.F., Heimer R., Verevochkin S.V., Ryder R.W., et al. HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr 41 5 (2006) 657-663
8. Krasnoselskikh T.V., Verevochkin S.V., Levchenko Y., Glubokovskaya M.M., Gagarina S.Y., Timofeeva M.Y., et al. Preliminary results of the laboratory follow-up on a group of injecting drug users within the framework of Randomized Controlled Trial of Russia IDU Peer Network HIV Prevention Intervention. Russ J AIDS Cancer Public Health 11 1 (2007) 115-116
9. Verevochkin S.V. Detection of recent HIV infections and incidence estimations among high risk patients. Russ J AIDS Cancer Public Health 11 1 (2007) 131
10. Karita E., Price M., Hunter E., Chomba E., Allen S., Fei L., et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 21 4 (2007) 403-408
11. Nabatov A.A., Masharsky A.E., Verevochkin S.V., Emelyanov A.V., Lukashov V.V., Heimer R., et al. The rate of epidemiological and virological changes during the transition from nascent to concentrated HIV epidemic stage in the former Soviet Union countries. AIDS Res Hum Retroviruses 23 2 (2007) 183-192
12. Masharsky A.E., Klimov N.A., and Kozlov A.P. Molecular cloning and analysis of full-length genome of HIV type 1 strains prevalent in countries of the former Soviet Union. AIDS Res Hum Retroviruses 19 10 (2003) 933-939
13. Chernyaeva E, Masharsky A, Verevochkin SV, Gagarina SY, Klimov N, Kozlov AP. Genetic diversity of HIV-1 strains among IDUs in 2002-2004 in St. Petersburg, Russia. Abstracts of AIDS Vaccine 2006 Conference, 2006. Amsterdam, the Netherlands. P08-05:117.
14. Dukhovlinova E., Masharsky A., Chernyaeva E., Solovjeva T., Verevochkin S.V., Gagarina S.Y., et al. Molecular Epidemiology of HIV-1 in St. Petersburg, Russia. Russ J AIDS Cancer Public Health 11 1 (2007) 111-112
15. Lukashov V.V., Huismans R., Rakhmanova A.G., Lisitsina Z.N., Akhtyrskaya N.A., Vlasov N.N., et al. Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. AIDS Res Hum Retroviruses 15 17 (1999) 1577-1583
16. Smolskaya T., Liitsola K., Zetterberg V., Golovanova E., Kevlova N., Konovalova N., et al. HIV epidemiology in the Northwestern Federal District of Russia: dominance of HIV type 1 subtype A. AIDS Res Hum Retroviruses 22 11 (2006) 1074-1080
17. Thomson M., Vasquez de Parga E., Rakhmanova A.G., Vinogradova A., Delgado E., et al. HIV-1 subtype A diversity in Russia: analysis of phylogenetic clusters and characterization of near full-length genome sequences of the predominant strain. Russ J AIDS Cancer Public Health 11 1 (2007) 131
18. UNAIDS. Ethical considerations in HIV preventive vaccine research. Geneva: UNAIDS; 2004.
19. Krupitsky E.M., Zvartau E.E., Masalov D.V., Tsoi M.V., Burakov A.M., Egorova V.Y., et al. Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Subst Abuse Treat 26 4 (2004) 285-294